NOVAVAX INC Insider Trading for March 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NOVAVAX INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NOVAVAX INC for March 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 25 2014 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Buy | P | 4.47 | 25,000 | 111,838 | 425,000 | 400 K to 425 K (+6.25 %) |
Mar 25 2014 | NVAX | NOVAVAX INC | DOUGLAS RICHARD | Director | Buy | P | 4.33 | 50,000 | 216,700 | 250,000 | 200 K to 250 K (+25.00 %) |
Mar 25 2014 | NVAX | NOVAVAX INC | PHILLIPS BARCLAY A | SVP, Chief Financia ... | Sell | P | 4.25 | 5,000 | 21,225 | 14,868 | 19.9 K to 14.9 K (-25.17 %) |
Mar 25 2014 | NVAX | NOVAVAX INC | Erck Stanley C | CEO and President | Sell | P | 4.27 | 10,000 | 42,698 | 84,868 | 94.9 K to 84.9 K (-10.54 %) |
Mar 21 2014 | NVAX | NOVAVAX INC | Modi Rajiv I. | Director | Sell | S | 4.69 | 1,000,000 | 4,690,000 | 9,500,000 | 10.5 M to 9.5 M (-9.52 %) |
Mar 21 2014 | NVAX | NOVAVAX INC | Modi Rajiv I. | Director | Sell | S | 4.99 | 1,000,000 | 4,990,000 | 10,500,000 | 11.5 M to 10.5 M (-8.70 %) |
Mar 21 2014 | NVAX | NOVAVAX INC | Modi Rajiv I. | Director | Sell | S | 5.17 | 1,000,000 | 5,170,000 | 11,500,000 | 12.5 M to 11.5 M (-8.00 %) |
Mar 21 2014 | NVAX | NOVAVAX INC | Cadila Pharmaceuticals Ltd | 10% Owner | Sell | S | 4.69 | 1,000,000 | 4,690,000 | 9,500,000 | 10.5 M to 9.5 M (-9.52 %) |
Mar 21 2014 | NVAX | NOVAVAX INC | Cadila Pharmaceuticals Ltd | 10% Owner | Sell | S | 4.99 | 1,000,000 | 4,990,000 | 10,500,000 | 11.5 M to 10.5 M (-8.70 %) |
Mar 21 2014 | NVAX | NOVAVAX INC | Cadila Pharmaceuticals Ltd | 10% Owner | Sell | S | 5.17 | 1,000,000 | 5,170,000 | 11,500,000 | 12.5 M to 11.5 M (-8.00 %) |
Mar 21 2014 | NVAX | NOVAVAX INC | Glenn Gregory M | SVP, Research and D ... | Sell | S | 5.48 | 29,000 | 158,778 | 4,102 | 33.1 K to 4.1 K (-87.61 %) |
Mar 21 2014 | NVAX | NOVAVAX INC | Glenn Gregory M | SVP, Research and D ... | Gift | G | 0.00 | 2,000 | 0 | 33,102 | 35.1 K to 33.1 K (-5.70 %) |
Mar 12 2014 | NVAX | NOVAVAX INC | Trizzino John | SVP, Commercial Ope ... | Option Exercise | A | 5.86 | 300,000 | 1,758,000 | 300,000 | |
Mar 07 2014 | NVAX | NOVAVAX INC | Hahn Timothy Jon | SVP, Manufacturing ... | Option Exercise | A | 6.05 | 125,000 | 756,250 | 625,000 | |
Mar 07 2014 | NVAX | NOVAVAX INC | Wilson Russell P | SVP, Business Devel ... | Option Exercise | A | 6.05 | 150,000 | 907,500 | 575,000 | |
Mar 07 2014 | NVAX | NOVAVAX INC | Glenn Gregory M | SVP, Research and D ... | Option Exercise | A | 6.05 | 175,000 | 1,058,750 | 889,000 | |
Mar 07 2014 | NVAX | NOVAVAX INC | PHILLIPS BARCLAY A | SVP, Chief Financia ... | Option Exercise | A | 6.05 | 150,000 | 907,500 | 450,000 | |
Mar 07 2014 | NVAX | NOVAVAX INC | Erck Stanley C | CEO and President | Option Exercise | A | 6.05 | 900,000 | 5,445,000 | 3,720,000 | |
Mar 07 2014 | NVAX | NOVAVAX INC | MCMANUS MICHAEL A JR | Director | Option Exercise | A | 6.05 | 30,000 | 181,500 | 225,000 | |
Mar 07 2014 | NVAX | NOVAVAX INC | MARSH JOHN O JR | Director | Option Exercise | A | 6.05 | 30,000 | 181,500 | 225,000 | |
Mar 07 2014 | NVAX | NOVAVAX INC | DOUGLAS RICHARD | Director | Option Exercise | A | 6.05 | 30,000 | 181,500 | 130,000 | |
Mar 07 2014 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | A | 6.05 | 30,000 | 181,500 | 655,000 | |
Mar 07 2014 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | A | 6.05 | 75,000 | 453,750 | 465,000 |